CA2585265A1 - Method to promote wound healing - Google Patents

Method to promote wound healing Download PDF

Info

Publication number
CA2585265A1
CA2585265A1 CA002585265A CA2585265A CA2585265A1 CA 2585265 A1 CA2585265 A1 CA 2585265A1 CA 002585265 A CA002585265 A CA 002585265A CA 2585265 A CA2585265 A CA 2585265A CA 2585265 A1 CA2585265 A1 CA 2585265A1
Authority
CA
Canada
Prior art keywords
substance
wound
mammal
administered
met
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002585265A
Other languages
English (en)
French (fr)
Inventor
Mark L. Witten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immuneregen Biosciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2585265A1 publication Critical patent/CA2585265A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002585265A 2004-10-27 2005-10-25 Method to promote wound healing Abandoned CA2585265A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62201504P 2004-10-27 2004-10-27
US60/622,015 2004-10-27
PCT/US2005/038646 WO2006047625A2 (en) 2004-10-27 2005-10-25 Method to promote wound healing

Publications (1)

Publication Number Publication Date
CA2585265A1 true CA2585265A1 (en) 2006-05-04

Family

ID=36228442

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002585265A Abandoned CA2585265A1 (en) 2004-10-27 2005-10-25 Method to promote wound healing

Country Status (6)

Country Link
US (1) US20080318869A1 (cg-RX-API-DMAC7.html)
EP (1) EP1809313A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008518020A (cg-RX-API-DMAC7.html)
AU (1) AU2005299341A1 (cg-RX-API-DMAC7.html)
CA (1) CA2585265A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006047625A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101621149B1 (ko) 2014-07-09 2016-05-16 계명대학교 산학협력단 만성 창상용 동물 모델
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
KR101825041B1 (ko) * 2016-04-07 2018-02-02 주식회사 바이오솔루션 물질 p를 포함하는 상처치유용 약학 조성물
WO2018014016A1 (en) * 2016-07-15 2018-01-18 New Amsterdam Sciences Substance and method for treating radiation exposure
JP6901801B2 (ja) * 2017-06-14 2021-07-14 バイオソリューション カンパニー・リミテッドBio Solution Co Ltd 物質pを含むしわの改善または抗炎症化粧料組成物
KR102158969B1 (ko) * 2018-10-19 2020-09-23 주식회사 바이오솔루션 물질 p를 포함하는 난치성 궤양 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616562A (en) * 1990-04-27 1997-04-01 Murphy; Christopher J. Methods and compositions using substance P to promote wound healing
US5945508A (en) * 1996-07-23 1999-08-31 Witten; Mark L. Substance P treatment for immunostimulation
JP4096115B2 (ja) * 2000-08-10 2008-06-04 輝夫 西田 皮膚創傷治癒促進剤
AU7776701A (en) * 2000-08-10 2002-02-25 Santen Pharmaceutical Co Ltd Skin wound healing promoters
US20060153789A1 (en) * 2002-12-18 2006-07-13 Witten Mark L Stimulation of hair regrowth
US20070154448A1 (en) * 2005-11-22 2007-07-05 Ted Reid Methods and compositions using Substance P to promote wound healing

Also Published As

Publication number Publication date
EP1809313A4 (en) 2008-01-23
WO2006047625A2 (en) 2006-05-04
AU2005299341A1 (en) 2006-05-04
WO2006047625A3 (en) 2006-07-27
EP1809313A2 (en) 2007-07-25
US20080318869A1 (en) 2008-12-25
JP2008518020A (ja) 2008-05-29

Similar Documents

Publication Publication Date Title
Vacas et al. High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages
Zhang et al. STING mediates neuroinflammatory response by activating NLRP3‐related pyroptosis in severe traumatic brain injury
Maier et al. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock
Pugh et al. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning
Adamec et al. Amygdala kindling, anxiety, and corticotrophin releasing factor (CRF)
Straube et al. Studies with cysteinamine and cysteine in x-irradiated animals
Shope Jr et al. Mechanism of protection from primary bovine viral diarrhea virus infection. I. The effects of dexamethasone
CA2534197A1 (en) Use of a vegf antagonist in combination with radiation therapy
US20080318869A1 (en) Method to Promote Wound Healing
EA022388B1 (ru) Способы лечения комбинированных лучевых и тепловых поражений
JP6150374B2 (ja) 放射線被ばく治療剤及び放射線被ばく治療方法
CA2129043C (en) Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and oedema
WO2021242642A1 (en) Composition for treating pain while minimizing the risk of opioid addiction
Kraicer et al. Adenohypophysial DNA and RNA after adrenalectomy, castration, and PTU
CN110559421B (zh) 胎盘转移因子的医药用途及其制备方法
CN1090491A (zh) 预防及治疗脓毒症的方法
RU2232501C2 (ru) Способ повышения естественной резистентности животных
Matte Growth hormone and isolation-induced aggression in wild male mice
McGIVERN et al. Effect of naloxone and housing conditions on shock-elicited reflexive fighting: Influence of immediate prior stress
Gomita et al. Effects of anxiolytic drugs on escape behavior induced by dorsal central gray stimulation in rats
CN103169966B (zh) 一种治疗系统性红斑狼疮的药物组合物
EP4506012A1 (en) Use of extracts from rabbit skin inflamed by vaccinia virus in treatment of alzheimer's disease
CN119185549B (zh) Sting抑制剂在制备治疗或预防心脏骤停后综合征药物中的应用
CN109701003A (zh) 一种北极熊用复方注射剂及其制备方法
JP2001057828A (ja) 癌性疼痛モデル動物及びそれを用いた癌性疼痛の強さの評価方法

Legal Events

Date Code Title Description
FZDE Discontinued